Quince Therapeutics, Inc. Restricted Cash, Current
Quince Therapeutics, Inc. (QNCX) had Restricted Cash, Current of $0 as of 2020-09-30, per its 10-Q filed 2020-11-12.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:RestrictedCashCurrent · last filed 2020-11-12
- 2020-09-30: Restricted Cash, Current $0.00.
- 2020-06-30: Restricted Cash, Current $0.00.
- 2020-03-31: Restricted Cash, Current $0.00.
- 2019-09-30: Restricted Cash, Current $250.00K.
| Period end | Restricted Cash, Current |
|---|---|
| 2020-09-30 | $0.00 10-Q · filed 2020-11-12 |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-14 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-12 |
| 2019-09-30 | $250.00K 10-Q · filed 2020-11-12 |
| 2019-06-30 | $250.00K 10-Q · filed 2020-08-14 |
| 2019-03-31 | $250.00K 10-Q · filed 2020-05-12 |
| 2018-06-30 | $50.00K 10-Q · filed 2019-08-09 |
| 2018-03-31 | $50.00K 10-Q · filed 2019-06-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |